FAF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.186000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.635600E-01
Normal-vs-Stage2
5.254000E-01
Normal-vs-Stage3
4.562200E-01
Normal-vs-Stage4
4.049600E-01
Stage1-vs-Stage2
4.056200E-01
Stage1-vs-Stage3
8.436100E-02
Stage1-vs-Stage4
8.428200E-01
Stage2-vs-Stage3
1.488630E-01
Stage2-vs-Stage4
6.680600E-01
Stage3-vs-Stage4
1.707980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.272000E-01
Normal-vs-AfricanAmerican
5.516400E-01
Normal-vs-Asian
7.619800E-01
Caucasian-vs-AfricanAmerican
9.528600E-01
Caucasian-vs-Asian
6.274800E-01
AfricanAmerican-vs-Asian
7.550800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.108800E-01
Normal-vs-Female
4.101200E-01
Male-vs-Female
3.444200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.227000E-01
Normal-vs-Age(41-60Yrs)
1.775980E-01
Normal-vs-Age(61-80Yrs)
7.433200E-01
Normal-vs-Age(81-100Yrs)
9.619200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.454800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.190400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.053590E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.025100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.241540E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.651600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.700000E-01
Normal-vs-Daily Drinker
7.357000E-01
Normal-vs-Weekly Drinker
7.057000E-01
Normal-vs-Occasional Drinker
3.681600E-01
Normal-vs-Social Drinker
1.334170E-01
Non Drinker-vs-Daily Drinker
3.842200E-01
Non Drinker-vs-Weekly Drinker
4.159000E-01
Non Drinker-vs-Occasional Drinker
3.981800E-02
Non Drinker-vs-Social Drinker
5.344400E-03
Daily Drinker-vs-Weekly Drinker
9.950800E-01
Daily Drinker-vs-Occasional Drinker
3.035200E-01
Daily Drinker-vs-Social Drinker
1.057800E-01
Weekly Drinker-vs-Occasional Drinker
3.260400E-01
Weekly Drinker-vs-Social Drinker
1.020380E-01
Occasional Drinker-vs-Social Drinker
5.642000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.161600E-01
Normal-vs-Grade 2
3.968500E-02
Normal-vs-Grade 3
5.006100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.309000E-01
Grade 1-vs-Grade 3
7.306500E-02
Grade 1-vs-Grade 4
2.161600E-01
Grade 2-vs-Grade 3
1.567760E-01
Grade 2-vs-Grade 4
3.968500E-02
Grade 3-vs-Grade 4
5.006100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.570800E-01
Normal-vs-NonDiabetic
4.572400E-01
Diabetic-vs-NonDiabetic
2.998000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.802200E-01
Normal-vs-NoPancreatitis
5.770600E-01
Pancreatitis-vs-NoPancreatitis
4.395200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.253000E-01
Normal-vs-N1
5.438400E-01
N0-vs-N1
8.596800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.826830E-01
Normal-vs-TP53-NonMutant
4.586600E-01
TP53-Mutant-vs-TP53-NonMutant
8.695800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
